Ocular Therapeutix (NASDAQ:OCUL) Stock Rating Reaffirmed by Piper Sandler
Ocular Therapeutix (NASDAQ:OCUL – Get Free Report)‘s stock had its “overweight” rating reiterated by research analysts at Piper Sandler in a note issued to investors on Friday, Benzinga reports. They presently have a $15.00 target price on the biopharmaceutical company’s stock. Piper Sandler’s target price would suggest a potential upside of 145.50% from the stock’s […]
More Stories
Ice Age 6: Boiling Point- Release Date, Voice Artist, and Synopsis
Hello, Ice Age fans! Your favourite animated animal movie is returning to the US theaters. Ice Age 6, or Ice...
I Will Find You: Sam Worthington’s Upcoming Series
Netflix is coming up with an all-new miniseries featuring the famous Sam Worthington as Jake Sully from the 2009 film...
Big Mistakes Season 2: Release Date, Cast, and Synopsis
Netflix’s hit comedy-thriller series, Big Mistakes, got an official renewal. The dark comedy series is bringing back the humor of...
Top 11 E-Commerce Companies in the USA for Your Convenience
There are a huge number of e-commerce companies in the USA. These companies are growing exponentially with the increasing demand....
Strip Law Season 2 Renewed? Check out the Renewal Status
Netflix is cancelling one series after another, and Strip Law, the American adult animated sitcom, is among them. Netflix has...
Netflix’s Upcoming Drama, Husbands in Action, is Releasing Soon
Are you also a Korean drama lover? If yes, Good news! An all-new comedy drama is arriving soon on Netflix....